This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Appel-da-Silva M.C., Narvaez G.A., Perez L.R.R., Drehmer L., Lewgoy J.: Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment. Med. Mycol. Case Rep. 18, 15–17 (2017)Appel-da-SilvaM.C.NarvaezG.A.PerezL.R.R.DrehmerL.LewgoyJ.Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment181517201710.1016/j.mmcr.2017.07.007553739528794958Search in Google Scholar
Ardiani A., Higgins J.P., Hodge J.W.: Vaccines based on whole recombinant Saccharomyces cerevisiae cells. FEMS Yeast Res. 10, 1060–1069 (2010)ArdianiA.HigginsJ.P.HodgeJ.W.Vaccines based on whole recombinant Saccharomyces cerevisiae cells1010601069201010.1111/j.1567-1364.2010.00665.x729509220707820Search in Google Scholar
Atıcı S., Soysal A., Karadeniz Cerit K., Yılmaz Ş., Aksu B., Kıyan G., Bakır M.: Catheter-related Saccharomyces cerevisiae fungemia following Saccharomyces boulardii probiotic treatment: In a child in intensive care unit and review of the literature. Med. Mycol. Case Rep. 15, 33–35 (2017)AtıcıS.SoysalA.Karadeniz CeritK.YılmazŞ.AksuB.KıyanG.BakırM.Catheter-related Saccharomyces cerevisiae fungemia following Saccharomyces boulardii probiotic treatment: In a child in intensive care unit and review of the literature153335201710.1016/j.mmcr.2017.02.002533350528280685Search in Google Scholar
Balakrishnan R., Park J., Karra K., Hitz B.C., Binkley G., Hong E.L., Sullivan J., Micklem G., Cherry J.M.: Yeast Mine-an integrated data warehouse for Saccharomyces cerevisiae data as a multipurpose tool-kit. Database: the journal of biological databases and curation, 2012, bar062-bar062 (2012)BalakrishnanR.ParkJ.KarraK.HitzB.C.BinkleyG.HongE.L.SullivanJ.MicklemG.CherryJ.M.Yeast Mine-an integrated data warehouse for Saccharomyces cerevisiae data as a multipurpose tool-kit2012bar062-bar0622012Search in Google Scholar
Barnett J.A.: A history of research on yeasts 10: foundations of yeast genetics. Yeast, 24, 799–845 (2007)BarnettJ.A.A history of research on yeasts 10: foundations of yeast genetics24799845200710.1002/yea.151317638318Search in Google Scholar
Bassetti S., Frei R., Zimmerli W.: Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii. Am. J. Med. 105, 71–72 (1998)BassettiS.FreiR.ZimmerliW.Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii1057172199810.1016/S0002-9343(98)00133-89688023Search in Google Scholar
Berg R., Bernasconi P., Fowler D., Gautreaux M.: Inhibition of Candida albicans translocation from the gastrointestinal tract of mice by oral administration of Saccharomyces boulardii. J. Infect. Dis. 168, 1314–1318 (1993)BergR.BernasconiP.FowlerD.GautreauxM.Inhibition of Candida albicans translocation from the gastrointestinal tract of mice by oral administration of Saccharomyces boulardii16813141318199310.1093/infdis/168.5.13148228371Search in Google Scholar
Berg R.D.: Bacterial translocation from the gastrointestinal tract. Trends Microbiol. 3, 149–154 (1995)BergR.D.Bacterial translocation from the gastrointestinal tract3149154199510.1007/978-1-4615-4143-1_210659341Search in Google Scholar
Bernardi T.L., de Melo Pereira G.V., Cardoso P.G., Dias E.S., Schwan R.F.: Saccharomyces cerevisiae strains associated with the production of cachaça: identification and characterization by traditional and molecular methods (PCR, PFGE and mtDNA-RFLP). World J. Microb. Biot. 24, 2705–2712 (2008)BernardiT.L.de Melo PereiraG.V.CardosoP.G.DiasE.S.SchwanR.F.Saccharomyces cerevisiae strains associated with the production of cachaça: identification and characterization by traditional and molecular methods (PCR, PFGE and mtDNA-RFLP)2427052712200810.1007/s11274-008-9799-ySearch in Google Scholar
Bharadwaj P., Martins R., Macreadie I.: Yeast as a model for studying Alzheimer’s disease. FEMS Yeast Res. 10, 961–969 (2010)BharadwajP.MartinsR.MacreadieI.Yeast as a model for studying Alzheimer’s disease10961969201010.1111/j.1567-1364.2010.00658.x20618869Search in Google Scholar
Bongomin F., Gago S., Oladele R.O., Denning D.W.: Global and multi-national prevalence of fungal diseases-estimate precision. J. Fungi (Basel), 3(4), pii: E57 (2017)BongominF.GagoS.OladeleR.O.DenningD.W.Global and multi-national prevalence of fungal diseases-estimate precision34pii:E57201710.3390/jof3040057575315929371573Search in Google Scholar
Botstein D., Fink G.R.: Yeast: an experimental organism for 21st century biology. Genetics, 189, 695–704 (2011)BotsteinD.FinkG.R.Yeast: an experimental organism for 21st century biology189695704201110.1534/genetics.111.130765321336122084421Search in Google Scholar
Boucaud C., Berrada K., Bouletreau P.: Septicémie à Saccharomyces boulardii après administration orale d’ultra-levure. Re’an-Urgences, 5:665 (1996)BoucaudC.BerradaK.BouletreauP.Septicémie à Saccharomyces boulardii après administration orale d’ultra-levure5665199610.1016/S1164-6756(05)80583-3Search in Google Scholar
Breves G., Walter C., Burmester M., Schröder B.: In vitro studies on the effects of Saccharomyces boulardii and Bacillus cereus var. toyoi on nutrient transport in pig jejunum. J. Anim. Physiol. An. N. 84, 9–20 (2000)BrevesG.WalterC.BurmesterM.SchröderB.In vitro studies on the effects of Saccharomyces boulardii and Bacillus cereus var. toyoi on nutrient transport in pig jejunum84920200010.1046/j.1439-0396.2000.00277.xSearch in Google Scholar
Burkhardt O., Köhnlein T., Pletz M., Welte T.: Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole. Scand. J. Infect. Dis. 37, 69–72 (2005)BurkhardtO.KöhnleinT.PletzM.WelteT.Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole376972200510.1080/0036554051002645415764194Search in Google Scholar
Buts J.-P., Dekeyser N., Stilmant C., Delem E., Smets F., Sokal E.: Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation. Pediatr. Res. 60, 24–29 (2006)ButsJ.-P.DekeyserN.StilmantC.DelemE.SmetsF.SokalE.Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation602429200610.1203/01.pdr.0000220322.31940.2916690953Search in Google Scholar
Buts J.P., Bernasconi P., Vaerman J.P., Dive C.: Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii. Dig. Dis. Sci. 35, 251–256 (1990)ButsJ.P.BernasconiP.VaermanJ.P.DiveC.Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii35251256199010.1007/BF015367712302983Search in Google Scholar
Cárdenas P.A., Garcés D., Prado-Vivar B., Flores N., Fornasini M., Cohen H., Salvador I., Cargua O., Baldeón M.E.: Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome. Eur. J. Clin. Microbiol. Infect. Dis. doi: 10.1007/s10096-020-03854-3 (2020)CárdenasP.A.GarcésD.Prado-VivarB.FloresN.FornasiniM.CohenH.SalvadorI.CarguaO.BaldeónM.E.Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiomedoi:10.1007/s10096-020-03854-3202032125555Open DOISearch in Google Scholar
Cassone M., Serra P., Mondello F., Girolamo A., Scafetti S., Pistella E., Venditti M.: Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism. J. Clin. Microbiol. 41, 5340–5343 (2003)CassoneM.SerraP.MondelloF.GirolamoA.ScafettiS.PistellaE.VendittiM.Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism4153405343200310.1128/JCM.41.11.5340-5343.200326246614605200Search in Google Scholar
Castagliuolo I., Valenick L., Riegler M., LaMont J.T., Pothoulakis C.: Saccharomyces boulardii protease inhibits Clostridium difficile toxin a and b-induced effects in human colonic mucosa. Gastroenterology, 114, A948–A949 (1998)CastagliuoloI.ValenickL.RieglerM.LaMontJ.T.PothoulakisC.Saccharomyces boulardii protease inhibits Clostridium difficile toxin a and b-induced effects in human colonic mucosa114A948A949199810.1016/S0016-5085(98)83862-6Search in Google Scholar
Cavalieri D., McGovern P.E., Hartl D.L., Mortimer R., Polsinelli M.: Evidence for S. cerevisiae fermentation in ancient wine. J. Mol. Evol., 57 Suppl 1, S226–232 (2003)CavalieriD.McGovernP.E.HartlD.L.MortimerR.PolsinelliM.Evidence for S. cerevisiae fermentation in ancient wine57Suppl 1S226232200310.1007/s00239-003-0031-215008419Search in Google Scholar
Cesaro S., Chinello P., Rossi L., Zanesco L.: Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii. Support Care Cancer, 8, 504–505 (2000)CesaroS.ChinelloP.RossiL.ZanescoL.Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii8504505200010.1007/s00520000012311094997Search in Google Scholar
Chakravarty S., Parashar A., Acharyya S.: Saccharomyces cerevisiae sepsis following probiotic therapy in an infant. Indian Pediatr. 56, 971–972 (2019)ChakravartyS.ParasharA.AcharyyaS.Saccharomyces cerevisiae sepsis following probiotic therapy in an infant56971972201910.1007/s13312-019-1655-7Search in Google Scholar
Chen L., Oshima J.: Werner Syndrome. J. Biomed. Biotechnol. 2, 46–54 (2002)ChenL.OshimaJ.Werner Syndrome24654200210.1155/S111072430220101115378412488583Search in Google Scholar
Chen X., Kokkotou E.G., Mustafa N., Bhaskar K.R., Sougioultzis S., O’Brien M., Pothoulakis C., Kelly C.P.: Saccharomyces boulardii Inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin a-induced enteritis. J. Biol. Chem. 281, 24449–24454 (2006)ChenX.KokkotouE.G.MustafaN.BhaskarK.R.SougioultzisS.O’BrienM.PothoulakisC.KellyC.P.Saccharomyces boulardii Inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin a-induced enteritis2812444924454200610.1074/jbc.M60520020016816386Search in Google Scholar
Cherifi S., Robberecht J., Miendje Y.: Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis. Acta Clin. Belg. 59, 223–224 (2004)CherifiS.RobberechtJ.MiendjeY.Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis59223224200410.1179/acb.2004.03315597730Search in Google Scholar
Choi C.H., Jo S.Y., Park H.J., Chang S.K., Byeon J.-S., Myung S.-J.: A randomized, double-blind, placebo-controlled multicenter trial of Saccharomyces boulardii in irritable bowel syndrome: effect on quality of life. J. Clin. Gastroenterol. 45, 679–683 (2011)ChoiC.H.JoS.Y.ParkH.J.ChangS.K.ByeonJ.-S.MyungS.-J.A randomized, double-blind, placebo-controlled multicenter trial of Saccharomyces boulardii in irritable bowel syndrome: effect on quality of life45679683201110.1097/MCG.0b013e318204593e21301358Search in Google Scholar
Cohen L., Ranque S., Raoult D.: Saccharomyces cerevisiae boulardii transient fungemia after intravenous self-inoculation. Med. Mycol. Case Rep. 2, 63–64 (2013)CohenL.RanqueS.RaoultD.Saccharomyces cerevisiae boulardii transient fungemia after intravenous self-inoculation26364201310.1016/j.mmcr.2013.02.003388594924432219Search in Google Scholar
Colak T., Ipek T., Paksoy M., Polat E., Uygun N., Kayabaşi B.: The effects of cefephim, G-CSF, and sucralfate on bacterial translocation in experimentally induced acute pancreatitis. Surg. Today, 31, 502–506 (2001)ColakT.IpekT.PaksoyM.PolatE.UygunN.KayabaşiB.The effects of cefephim, G-CSF, and sucralfate on bacterial translocation in experimentally induced acute pancreatitis31502506200110.1007/s00595017010911428601Search in Google Scholar
Costa R.L., Moreira J., Lorenzo A., Lamas C.C.: Infectious complications following probiotic ingestion: a potentially underestimated problem? A systematic review of reports and case series. BMC Complement Altern. Med. 18, 329 (2018)CostaR.L.MoreiraJ.LorenzoA.LamasC.C.Infectious complications following probiotic ingestion: a potentially underestimated problem? A systematic review of reports and case series18329201810.1186/s12906-018-2394-3629212030541524Search in Google Scholar
Czerucka D., Piche T., Rampal P.: Review article: yeast as probiotics – Saccharomyces boulardii. Aliment. Pharmacol. Ther. 26, 767–778 (2007)CzeruckaD.PicheT.RampalP.Review article: yeast as probiotics – Saccharomyces boulardii26767778200710.1111/j.1365-2036.2007.03442.x17767461Search in Google Scholar
Czerucka D., Roux I., Rampal P.: Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3’,5’-cyclic monophosphate induction in intestinal cells. Gastroenterology, 106, 65–72 (1994)CzeruckaD.RouxI.RampalP.Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3’,5’-cyclic monophosphate induction in intestinal cells1066572199410.1016/S0016-5085(94)94403-28276210Search in Google Scholar
Dahan S., Dalmasso G., Imbert V., Peyron J.F., Rampal P., Czerucka D.: Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells. Infect. Immun. 71, 766–773 (2003)DahanS.DalmassoG.ImbertV.PeyronJ.F.RampalP.CzeruckaD.Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells71766773200310.1128/IAI.71.2.766-773.200314535512540556Search in Google Scholar
Dalmasso G., Cottrez F., Imbert V., Lagadec P., Peyron J.F., Rampal P., Czerucka D., Groux H., Foussat A., Brun V.: Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes. Gastroenterology, 131, 1812–1825 (2006)DalmassoG.CottrezF.ImbertV.LagadecP.PeyronJ.F.RampalP.CzeruckaD.GrouxH.FoussatA.BrunV.Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes13118121825200610.1053/j.gastro.2006.10.00117087945Search in Google Scholar
Dauby N.: Risks of Saccharomyces boulardii-containing probiotics for the prevention of Clostridium difficile infection in the elderly. Gastroenterology, 153, 1450–1451 (2017)DaubyN.Risks of Saccharomyces boulardii-containing probiotics for the prevention of Clostridium difficile infection in the elderly15314501451201710.1053/j.gastro.2017.04.05428988917Search in Google Scholar
de Llanos R., Llopis S., Molero G., Querol A., Gil C., Fernández-Espinar M.T.: In vivo virulence of commercial Saccharomyces cerevisiae strains with pathogenicity-associated phenotypical traits. Int. J. Food Microbiol. 144, 393–399 (2011)de LlanosR.LlopisS.MoleroG.QuerolA.GilC.Fernández-EspinarM.T.In vivo virulence of commercial Saccharomyces cerevisiae strains with pathogenicity-associated phenotypical traits144393399201110.1016/j.ijfoodmicro.2010.10.02521081253Search in Google Scholar
de Llanos R., Querol A., Pemán J., Gobernado M., Fernández-Espinar M.T.: Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections. Int. J. Food Microbiol. 110, 286–290 (2006)de LlanosR.QuerolA.PemánJ.GobernadoM.Fernández-EspinarM.T.Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections110286290200610.1016/j.ijfoodmicro.2006.04.02316782223Search in Google Scholar
Domingues L., Oliveira C., Castro I., Lima N., Teixeira A.J.: Production of β-galactosidase from recombinant Saccharomyces cerevisiae grown on lactose. J. Chem. Technol. Biot. 79, 809–815 (2004)DominguesL.OliveiraC.CastroI.LimaN.TeixeiraA.J.Production of β-galactosidase from recombinant Saccharomyces cerevisiae grown on lactose79809815200410.1002/jctb.1025Search in Google Scholar
Edwards-Ingram L., Gitsham P., Burton N., Warhurst G., Clarke I., Hoyle D., Oliver S.G., Stateva L.: Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae. Appl. Environ. Microbiol. 73, 2458–2467 (2007)Edwards-IngramL.GitshamP.BurtonN.WarhurstG.ClarkeI.HoyleD.OliverS.G.StatevaL.Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae7324582467200710.1128/AEM.02201-06185559417293506Search in Google Scholar
Ellouze O., Berthoud V., Mervant M., Parthiot J.P., Girard C.: Septic shock due to Saccharomyces boulardii. Med. Mal. Infect. 46, 104–105 (2016)EllouzeO.BerthoudV.MervantM.ParthiotJ.P.GirardC.Septic shock due to Saccharomyces boulardii46104105201610.1016/j.medmal.2015.12.00326774277Search in Google Scholar
Elmer G.W., Surawicz C.M., McFarland L.V.: Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA, 275, 870–876 (1996)ElmerG.W.SurawiczC.M.McFarlandL.V.Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections275870876199610.1001/jama.275.11.8708596226Search in Google Scholar
Enache-Angoulvant A., Hennequin C.: Invasive Saccharomyces infection: a comprehensive review. Clin. Infect. Dis. 41, 1559–1568 (2005)Enache-AngoulvantA.HennequinC.Invasive Saccharomyces infection: a comprehensive review4115591568200510.1086/49783216267727Search in Google Scholar
Eren Z., Gurol Y., Sonmezoglu M., Eren H.S., Celik G., Kantarci G.: [Saccharomyces cerevisiae fungemia in an elderly patient following probiotic treatment]. Mikrobiyol Bul. 48, 351–355 (2014)ErenZ.GurolY.SonmezogluM.ErenH.S.CelikG.KantarciG.[Saccharomyces cerevisiae fungemia in an elderly patient following probiotic treatment]48351355201410.5578/mb.697024819274Search in Google Scholar
Fadhel M., Patel S., Liu E., Levitt M., Asif A.: Fungemia in a critically ill patient with acute cholangitis and long term probiotic use. Med. Mycol. Case Rep. 23, 23–25 (2019)FadhelM.PatelS.LiuE.LevittM.AsifA.Fungemia in a critically ill patient with acute cholangitis and long term probiotic use232325201910.1016/j.mmcr.2018.11.003625179130505677Search in Google Scholar
Fietto J.L.R., Araújo R.S., Valadão F.N., Fietto L.G., Brandão R.L., Neves M.J., Gomes F.C.O., Nicoli J.R., Castro I.M.: Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii. Can. J. Microbiol. 50, 615–621 (2004)FiettoJ.L.R.AraújoR.S.ValadãoF.N.FiettoL.G.BrandãoR.L.NevesM.J.GomesF.C.O.NicoliJ.R.CastroI.M.Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii50615621200410.1139/w04-05015467787Search in Google Scholar
Fredenucci I., Chomarat M., Boucaud C., Flandrois J.P.: Saccharomyces boulardii fungemia in a patient receiving Ultra-levure therapy. Clin. Infect. Dis. 27, 222–223 (1998)FredenucciI.ChomaratM.BoucaudC.FlandroisJ.P.Saccharomyces boulardii fungemia in a patient receiving Ultra-levure therapy27222223199810.1086/5176859675488Search in Google Scholar
Geyik M.F., Aldemir M., Hosoglu S., Ayaz C., Satilmis S., Buyukbayram H., Kokoglu O.F.: The effects of Saccharomyces boulardii on bacterial translocation in rats with obstructive jaundice. Ann. R. Coll. Surg. Engl. 88, 176–180 (2006)GeyikM.F.AldemirM.HosogluS.AyazC.SatilmisS.BuyukbayramH.KokogluO.F.The effects of Saccharomyces boulardii on bacterial translocation in rats with obstructive jaundice88176180200610.1308/003588406X94986196404016551414Search in Google Scholar
Girardin S.E., Philpott D.J. i wsp.: CARD4/Nod1 mediates NF-κB and JNK activation by invasive Shigella flexneri. EMBO Reports, 2, 736–742 (2001)GirardinS.E.PhilpottD.J.i wsp.CARD4/Nod1 mediates NF-κB and JNK activation by invasive Shigella flexneri2736742200110.1093/embo-reports/kve155108399211463746Search in Google Scholar
Giusto C., Iacumin L., Comi G., Buiatti S., Manzano M.: PCR-TTGE and RAPD-PCR Techniques to analyze Saccharomyces cerevisiae and Saccharomyces carlsbergensis isolated from craft beers. J. I. Brewing, 112, 340–345 (2006)GiustoC.IacuminL.ComiG.BuiattiS.ManzanoM.PCR-TTGE and RAPD-PCR Techniques to analyze Saccharomyces cerevisiae and Saccharomyces carlsbergensis isolated from craft beers112340345200610.1002/j.2050-0416.2006.tb00740.xSearch in Google Scholar
Goffeau A., Oliver S.G. i wsp.: Life with 6000 genes. Science, 274, 546, 563–547 (1996)GoffeauA.OliverS.G.i wsp.Life with 6000 genes274546563547199610.1126/science.274.5287.5468849441Search in Google Scholar
Gokhale K.C., Newnam G.P., Sherman M.Y., Chernoff Y.O.: Modulation of prion-dependent polyglutamine aggregation and toxicity by chaperone proteins in the yeast model. J. Biol. Chem. 280, 22809–22818 (2005)GokhaleK.C.NewnamG.P.ShermanM.Y.ChernoffY.O.Modulation of prion-dependent polyglutamine aggregation and toxicity by chaperone proteins in the yeast model2802280922818200510.1074/jbc.M50039020015824100Search in Google Scholar
Graf C., Gavazzi G.: Saccharomyces cerevisiae fungemia in an immunocompromised patient not treated with Saccharomyces boulardii preparation. J. Infect. 54, 310–311 (2007)GrafC.GavazziG.Saccharomyces cerevisiae fungemia in an immunocompromised patient not treated with Saccharomyces boulardii preparation54310311200710.1016/j.jinf.2006.01.01916545460Search in Google Scholar
Graff S., Chaumeil J.C., Boy P., Lai-Kuen R., Charrueau C.: Influence of pH conditions on the viability of Saccharomyces boulardii yeast. J. Gen. Appl. Microbiol. 54, 221–227 (2008)GraffS.ChaumeilJ.C.BoyP.Lai-KuenR.CharrueauC.Influence of pH conditions on the viability of Saccharomyces boulardii yeast54221227200810.2323/jgam.54.22118802321Search in Google Scholar
Gupta P., Singh Y.P., Taneja A.: A friend or foe in ICU (A case report with solution). Indian J. Crit. Care Med. 23, 430–431 (2019)GuptaP.SinghY.P.TanejaA.A friend or foe in ICU (A case report with solution)23430431201910.5005/jp-journals-10071-23239677572331645830Search in Google Scholar
Guslandi M.: Saccharomyces boulardii plus rifaximin in mesalamine-intolerant ulcerative colitis. J. Clin. Gastroenterol. 44, 385 (2010)GuslandiM.Saccharomyces boulardii plus rifaximin in mesalamine-intolerant ulcerative colitis44385201010.1097/MCG.0b013e3181cb423320104184Search in Google Scholar
Guslandi M.: Treatment of irritable bowel syndrome with Saccharomyces boulardii. J. Clin. Gastroenterol. 45, 740–741 (2011)GuslandiM.Treatment of irritable bowel syndrome with Saccharomyces boulardii45740741201110.1097/MCG.0b013e3182166c7621555955Search in Google Scholar
Hackel B.J., Huang D., Bubolz J.C., Wang X.X., Shusta E.V.: Production of soluble and active transferrin receptor-targeting single-chain antibody using Saccharomyces cerevisiae. Pharm. Res. 23, 790–797 (2006)HackelB.J.HuangD.BubolzJ.C.WangX.X.ShustaE.V.Production of soluble and active transferrin receptor-targeting single-chain antibody using Saccharomyces cerevisiae23790797200610.1007/s11095-006-9778-716550469Search in Google Scholar
Hayford A.E., Jespersen L.: Characterization of Saccharomyces cerevisiae strains from spontaneously fermented maize dough by profiles of assimilation, chromosome polymorphism, PCR and MAL genotyping. J. Appl. Microbiol. 86, 284–294 (1999)HayfordA.E.JespersenL.Characterization of Saccharomyces cerevisiae strains from spontaneously fermented maize dough by profiles of assimilation, chromosome polymorphism, PCR and MAL genotyping86284294199910.1046/j.1365-2672.1999.00653.x10063628Search in Google Scholar
Hennequin C., Kauffmann-Lacroix C., Jobert A., Viard J.P., Ricour C., Jacquemin J.L., Berche P.: Possible role of catheters in Saccharomyces boulardii fungemia. Eur. J. Clin. Microbiol. Infect. Dis. 19, 16–20 (2000)HennequinC.Kauffmann-LacroixC.JobertA.ViardJ.P.RicourC.JacqueminJ.L.BercheP.Possible role of catheters in Saccharomyces boulardii fungemia191620200010.1007/s10096005000310706174Search in Google Scholar
Hennequin C., Thierry A., Richard G.F., Lecointre G., Nguyen H.V., Gaillardin C., Dujon B.: Microsatellite typing as a new tool for identification of Saccharomyces cerevisiae strains. J. Clin. Microbiol. 39, 551–559 (2001)HennequinC.ThierryA.RichardG.F.LecointreG.NguyenH.V.GaillardinC.DujonB.Microsatellite typing as a new tool for identification of Saccharomyces cerevisiae strains39551559200110.1128/JCM.39.2.551-559.20018777411158105Search in Google Scholar
Henry S., D’Hondt L., André M., Holemans X., Canon J.L.: Saccharomyces cerevisiae fungemia in a head and neck cancer patient: a case report and review of the literature. Acta Clin. Belg. 59, 220–222 (2004)HenryS.D’HondtL.AndréM.HolemansX.CanonJ.L.Saccharomyces cerevisiae fungemia in a head and neck cancer patient: a case report and review of the literature59220222200410.1179/acb.2004.03215597729Search in Google Scholar
Herbrecht R., Nivoix Y.: Saccharomyces cerevisiae fungemia: an adverse effect of Saccharomyces boulardii probiotic administration. Clin. Infect. Dis. 40, 1635–1637 (2005)HerbrechtR.NivoixY.Saccharomyces cerevisiae fungemia: an adverse effect of Saccharomyces boulardii probiotic administration4016351637200510.1086/42992615889361Search in Google Scholar
Hermans D., De Keyser N., Marandi S., Chae Y.H.E., Lambotte L., Buts J.-P.: Saccharomyces boulardii upgrades cellular adaptation following proximal enterectomy in rats. Pediatr. Res. 45, 112–112 (1999)HermansD.De KeyserN.MarandiS.ChaeY.H.E.LambotteL.ButsJ.-P.Saccharomyces boulardii upgrades cellular adaptation following proximal enterectomy in rats45112112199910.1203/00006450-199904020-00664Search in Google Scholar
Herschleb J., Ananiev G., Schwartz D.C.: Pulsed-field gel electrophoresis. Nature Protocols, 2, 677–684 (2007)HerschlebJ.AnanievG.SchwartzD.C.Pulsed-field gel electrophoresis2677684200710.1038/nprot.2007.9417406630Search in Google Scholar
Imre A., Rácz H.V., Antunovics Z., Rádai Z., Kovács R., Lopandic K., Pócsi I., Pfliegler W.P.: A new, rapid multiplex PCR method identifies frequent probiotic origin among clinical Saccharomyces isolates. Microbiol. Res. 227, 126298 (2019)ImreA.RáczH.V.AntunovicsZ.RádaiZ.KovácsR.LopandicK.PócsiI.PflieglerW.P.A new, rapid multiplex PCR method identifies frequent probiotic origin among clinical Saccharomyces isolates227126298201910.1016/j.micres.2019.12629831421716Search in Google Scholar
Kara I., Yıldırım F., Özgen Ö., Erganiş S., Aydoğdu M., Dizbay M., Gürsel G., Kalkanci A.: Saccharomyces cerevisiae fungemia after probiotic treatment in an intensive care unit patient. J. Mycol. Med. 28, 218–221 (2018)KaraI.YıldırımF.ÖzgenÖ.ErganişS.AydoğduM.DizbayM.GürselG.KalkanciA.Saccharomyces cerevisiae fungemia after probiotic treatment in an intensive care unit patient28218221201810.1016/j.mycmed.2017.09.00329132794Search in Google Scholar
Kazachenko K.Y.E., B. D. Kozlov, D. G.: Activities of elements of the yeast α-factor precursor leader at different stages of somatropin secretion by Saccharomyces cerevisiae. Appl. Biochem. 50, 829–834 (2014)KazachenkoK.Y.E.KozlovB. D.D. G.Activities of elements of the yeast α-factor precursor leader at different stages of somatropin secretion by Saccharomyces cerevisiae50829834201410.1134/S000368381409004XSearch in Google Scholar
Khatri I., Tomar R., Ganesan K., Prasad G.S., Subramanian S.: Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii. Sci. Rep. 7, 371 (2017)KhatriI.TomarR.GanesanK.PrasadG.S.SubramanianS.Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii7371201710.1038/s41598-017-00414-2542847928336969Search in Google Scholar
Kim M.D., Han K.C., Kang H.A., Rhee S.K., Seo J.H.: Coexpression of BiP increased antithrombotic hirudin production in recombinant Saccharomyces cerevisiae. J. Biotechnol. 101, 81–87 (2003)KimM.D.HanK.C.KangH.A.RheeS.K.SeoJ.H.Coexpression of BiP increased antithrombotic hirudin production in recombinant Saccharomyces cerevisiae1018187200310.1016/S0168-1656(02)00288-2Search in Google Scholar
Kjeldsen T.: Yeast secretory expression of insulin precursors. Appl. Microbiol. Biotechnol. 54, 277–286 (2000)KjeldsenT.Yeast secretory expression of insulin precursors54277286200010.1007/s00253000040211030562Search in Google Scholar
Klingberg T.D., Lesnik U., Arneborg N., Raspor P., Jespersen L.: Comparison of Saccharomyces cerevisiae strains of clinical and nonclinical origin by molecular typing and determination of putative virulence traits. FEMS Yeast Res. 8, 631–640 (2008)KlingbergT.D.LesnikU.ArneborgN.RasporP.JespersenL.Comparison of Saccharomyces cerevisiae strains of clinical and nonclinical origin by molecular typing and determination of putative virulence traits8631640200810.1111/j.1567-1364.2008.00365.x243033218355272Search in Google Scholar
Kumar R., Kumar P.: Yeast-based vaccines: New perspective in vaccine development and application. FEMS Yeast Res. 19, pii: foz007 (2019)KumarR.KumarP.Yeast-based vaccines: New perspective in vaccine development and application19pii:foz007201910.1093/femsyr/foz00730668686Search in Google Scholar
Lestin F., Pertschy A., Rimek D.: [Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities]. Dtsch. Med. Wochenschr. 128, 2531–2533 (2003)LestinF.PertschyA.RimekD.[Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities]128253125332003Search in Google Scholar
Lherm T., Monet C., Nougière B., Soulier M., Larbi D., Le Gall C., Caen D., Malbrunot C.: Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med. 28, 797–801 (2002)LhermT.MonetC.NougièreB.SoulierM.LarbiD.Le GallC.CaenD.MalbrunotC.Seven cases of fungemia with Saccharomyces boulardii in critically ill patients28797801200210.1007/s00134-002-1267-912107689Search in Google Scholar
Liti G.: The fascinating and secret wild life of the budding yeast S. cerevisiae. Elife, 4, (2015)LitiG.The fascinating and secret wild life of the budding yeast S. cerevisiae4201510.7554/eLife.05835437346125807086Search in Google Scholar
Lolis N., Veldekis D., Moraitou H., Kanavaki S., Velegraki A., Triandafyllidis C., Tasioudis C., Pefanis A., Pneumatikos I.: Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin. Crit. Care, 12, 414 (2008)LolisN.VeldekisD.MoraitouH.KanavakiS.VelegrakiA.TriandafyllidisC.TasioudisC.PefanisA.PneumatikosI.Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin12414200810.1186/cc6843244758018423057Search in Google Scholar
Lungarotti M.S., Mezzetti D., Radicioni M.: Methaemoglobinaemia with concurrent blood isolation of Saccharomyces and Candida. Arch. Dis. Child Fetal Neonatal. Ed. 88, F446 (2003)LungarottiM.S.MezzettiD.RadicioniM.Methaemoglobinaemia with concurrent blood isolation of Saccharomyces and Candida88F446200310.1136/fn.88.5.F446Search in Google Scholar
Luo J., He M., Li W., Zhang T.: Expression and secretion of alpha-amylase and glucoamylase in Saccharomyces cerevisiae. Chin. J. Biotechnol. 10, 241–248 (1994)LuoJ.HeM.LiW.ZhangT.Expression and secretion of alpha-amylase and glucoamylase in Saccharomyces cerevisiae102412481994Search in Google Scholar
Łukaszewicz M.: Saccharomyces cerevisiae var. boulardii – probiotic yeast. (w) Probiotics, red. Rigobelo E., IntechOpen, Londyn, Wielka Brytania (2012)ŁukaszewiczM.red.RigobeloE.IntechOpenLondyn, Wielka Brytania201210.5772/50105Search in Google Scholar
Martin G.S., Mannino D.M., Eaton S., Moss M.: The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348, 1546–1554 (2003)MartinG.S.ManninoD.M.EatonS.MossM.The epidemiology of sepsis in the United States from 1979 through 200034815461554200310.1056/NEJMoa02213912700374Search in Google Scholar
Martin I.W., Zhang S.X. i wsp.: Saccharomyces boulardii probiotic-associated fungemia: questioning the safety of this preventive probiotic’s use. Diagn. Microbiol. Infect. Dis. 87, 286–288 (2017)MartinI.W.ZhangS.X.i wsp.Saccharomyces boulardii probiotic-associated fungemia: questioning the safety of this preventive probiotic’s use87286288201710.1016/j.diagmicrobio.2016.12.00428024866Search in Google Scholar
Martinez M.J., Roy S., Archuletta A.B., Wentzell P.D., Anna-Arriola S.S., Rodriguez A.L., Aragon A.D., Quiñones G.A., Allen C., Werner-Washburne M.: Genomic analysis of stationary-phase and exit in Saccharomyces cerevisiae: gene expression and identification of novel essential genes. Mol. Biol. Cell, 15, 5295–5305 (2004)MartinezM.J.RoyS.ArchulettaA.B.WentzellP.D.Anna-ArriolaS.S.RodriguezA.L.AragonA.D.QuiñonesG.A.AllenC.Werner-WashburneM.Genomic analysis of stationary-phase and exit in Saccharomyces cerevisiae: gene expression and identification of novel essential genes1552955305200410.1091/mbc.e03-11-085653201115456898Search in Google Scholar
Martins F.S., Teixeira M.M. i wsp.: Inhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in mice. Microbes and Infection, 15, 270–279 (2013)MartinsF.S.TeixeiraM.M.i wsp.Inhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in mice15270279201310.1016/j.micinf.2012.12.00723376166Search in Google Scholar
McAleer W.J., Buynak E.B., Maigetter R.Z., Wampler D.E., Miller W.J., Hilleman M.R.: Human hepatitis B vaccine from recombinant yeast. Nature, 307, 178–180 (1984)McAleerW.J.BuynakE.B.MaigetterR.Z.WamplerD.E.MillerW.J.HillemanM.R.Human hepatitis B vaccine from recombinant yeast307178180198410.1038/307178a06318124Search in Google Scholar
McCullough M.J., Clemons K.V., McCusker J.H., Stevens D.A.: Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.). J. Clin. Microbiol. 36, 2613–2617 (1998)McCulloughM.J.ClemonsK.V.McCuskerJ.H.StevensD.A.Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.)3626132617199810.1128/JCM.36.9.2613-2617.19981051729705402Search in Google Scholar
McFarland L.V.: Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J. Gastroenterol. 16, 2202–2222 (2010)McFarlandL.V.Systematic review and meta-analysis of Saccharomyces boulardii in adult patients1622022222201010.3748/wjg.v16.i18.2202286821320458757Search in Google Scholar
Mitterdorfer G., Mayer H.K., Kneifel W., Viernstein H.: Clustering of Saccharomyces boulardii strains within the species S. cerevisiae using molecular typing techniques. J. Appl. Microbiol. 93, 521–530 (2002)MitterdorferG.MayerH.K.KneifelW.ViernsteinH.Clustering of Saccharomyces boulardii strains within the species S. cerevisiae using molecular typing techniques93521530200210.1046/j.1365-2672.2002.01710.x12234334Search in Google Scholar
Molnar O., Messner R., Prillinger H., Stahl U., Slavikova E.: Genotypic identification of Saccharomyces species using random amplified polymorphic DNA analysis. Syst. Appl. Microbiol. 18, 136–145 (1995)MolnarO.MessnerR.PrillingerH.StahlU.SlavikovaE.Genotypic identification of Saccharomyces species using random amplified polymorphic DNA analysis18136145199510.1016/S0723-2020(11)80461-3Search in Google Scholar
Moriguchi K., Yamamoto S., Tanaka K., Kurata N., Suzuki K.: Trans-kingdom horizontal DNA transfer from bacteria to yeast is highly plastic due to natural polymorphisms in auxiliary nonessential recipient genes. PLoS One, 8, e74590 (2013)MoriguchiK.YamamotoS.TanakaK.KurataN.SuzukiK.Trans-kingdom horizontal DNA transfer from bacteria to yeast is highly plastic due to natural polymorphisms in auxiliary nonessential recipient genes8e74590201310.1371/journal.pone.0074590377284224058593Search in Google Scholar
Mumy K.L., Chen X., Kelly C.P., McCormick B.A.: Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G599–609 (2008)MumyK.L.ChenX.KellyC.P.McCormickB.A.Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events294G599609200810.1152/ajpgi.00391.2007321275418032477Search in Google Scholar
Muñoz P., Bouza E., Cuenca-Estrella M., Eiros J.M., Pérez M.J., Sánchez-Somolinos M., Rincón C., Hortal J., Peláez T.: Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin. Infect. Dis. 40, 1625–1634 (2005)MuñozP.BouzaE.Cuenca-EstrellaM.EirosJ.M.PérezM.J.Sánchez-SomolinosM.RincónC.HortalJ.PeláezT.Saccharomyces cerevisiae fungemia: an emerging infectious disease4016251634200510.1086/42991615889360Search in Google Scholar
Murzyn A., Krasowska A., Augustyniak D., Majkowska-Skrobek G., Łukaszewicz M., Dziadkowiec D.: The effect of Saccharomyces boulardii on Candida albicans-infected human intestinal cell lines Caco-2 and Intestin 407. FEMS Microbiol. Lett. 310, 17–23 (2010)MurzynA.KrasowskaA.AugustyniakD.Majkowska-SkrobekG.ŁukaszewiczM.DziadkowiecD.The effect of Saccharomyces boulardii on Candida albicans-infected human intestinal cell lines Caco-2 and Intestin 4073101723201010.1111/j.1574-6968.2010.02037.x20629753Search in Google Scholar
Niault M., Thomas F., Prost J., Ansari F.H., Kalfon P.: Fungemia due to Saccharomyces species in a patient treated with enteral Saccharomyces boulardii. Clin. Infect. Dis. 28, 930 (1999)NiaultM.ThomasF.ProstJ.AnsariF.H.KalfonP.Fungemia due to Saccharomyces species in a patient treated with enteral Saccharomyces boulardii28930199910.1086/51725510825077Search in Google Scholar
Perapoch J., Planes A.M., Querol A., López V., Martínez-Bendayán I., Tormo R., Fernández F., Peguero G., Salcedo S.: Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with ultra-levura. Eur. J. Clin. Microbiol. Infect. Dis. 19, 468–470 (2000)PerapochJ.PlanesA.M.QuerolA.LópezV.Martínez-BendayánI.TormoR.FernándezF.PegueroG.SalcedoS.Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with ultra-levura19468470200010.1007/s10096000029510947224Search in Google Scholar
Pérez-Torrado R., Querol A.: Opportunistic strains of Saccharomyces cerevisiae: A potential risk sold in food products. Front. Microbiol. 6, 1522 (2015)Pérez-TorradoR.QuerolA.Opportunistic strains of Saccharomyces cerevisiae: A potential risk sold in food products61522201510.3389/fmicb.2015.01522470530226779173Search in Google Scholar
Piechno S., Seguin P., Gangneux J.P.: [Saccharomyces boulardii fungal sepsis: beware of the yeast]. Can. J. Anaesth. 54, 245–246 (2007)PiechnoS.SeguinP.GangneuxJ.P.[Saccharomyces boulardii fungal sepsis: beware of the yeast]54245246200710.1007/BF0302265017331940Search in Google Scholar
Pletincx M., Legein J., Vandenplas Y.: Fungemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea. J. Pediatr. Gastroenterol. Nutr. 21, 113–115 (1995)PletincxM.LegeinJ.VandenplasY.Fungemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea21113115199510.1097/00005176-199507000-000228576803Search in Google Scholar
Pothoulakis C., Kelly C.P., Joshi M.A., Gao N., O’Keane C.J., Castagliuolo I., Lamont J.T.: Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology, 104, 1108–1115 (1993)PothoulakisC.KellyC.P.JoshiM.A.GaoN.O’KeaneC.J.CastagliuoloI.LamontJ.T.Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum10411081115199310.1016/0016-5085(93)90280-PSearch in Google Scholar
Psomas E., Andrighetto C., Litopoulou-Tzanetaki E., Lombardi A., Tzanetakis N.: Some probiotic properties of yeast isolates from infant faeces and Feta cheese. Int. J. Food Microbiol. 69, 125–133 (2001)PsomasE.AndrighettoC.Litopoulou-TzanetakiE.LombardiA.TzanetakisN.Some probiotic properties of yeast isolates from infant faeces and Feta cheese69125133200110.1016/S0168-1605(01)00580-311589551Search in Google Scholar
Rajkowska K., Kunicka-Styczyńska A.: Phenotypic and genotypic characterization of probiotic yeasts. Biotechnol. Biotec. Eq. 23, 662–665 (2009)RajkowskaK.Kunicka-StyczyńskaA.Phenotypic and genotypic characterization of probiotic yeasts23662665200910.1080/13102818.2009.10818511Search in Google Scholar
Rijnders B.J., Van Wijngaerden E., Verwaest C., Peetermans W.E.: Saccharomyces fungemia complicating Saccharomyces boulardii treatment in a non-immunocompromised host. Intensive Care Med. 26, 825 (2000)RijndersB.J.Van WijngaerdenE.VerwaestC.PeetermansW.E.Saccharomyces fungemia complicating Saccharomyces boulardii treatment in a non-immunocompromised host26825200010.1007/s00134005126110945412Search in Google Scholar
Riquelme A.J., Calvo M.A., Guzmán A.M., Depix M.S., García P., Pérez C., Arrese M., Labarca J.A.: Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients. J. Clin. Gastroenterol. 36, 41–43 (2003)RiquelmeA.J.CalvoM.A.GuzmánA.M.DepixM.S.GarcíaP.PérezC.ArreseM.LabarcaJ.A.Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients364143200310.1097/00004836-200301000-0001312488707Search in Google Scholar
Robak M., Walczak E.: Niekonwencjonalne drożdże w produkcji heterologicznych białek. Biotechnologia, 87, 20 (2009)RobakM.WalczakE.Niekonwencjonalne drożdże w produkcji heterologicznych białek87202009Search in Google Scholar
Rodrigues A.C., Cara D.C., Fretez S.H., Cunha F.Q., Viera E.C., Nicoli J.R., Viera L.Q.: Saccharomyces boulardii stimulates sIgA production and the pahgocytic system of gnobiotic mice. J. Appl. Microbiol. 89, 404–414 (2000)RodriguesA.C.CaraD.C.FretezS.H.CunhaF.Q.VieraE.C.NicoliJ.R.VieraL.Q.Saccharomyces boulardii stimulates sIgA production and the pahgocytic system of gnobiotic mice89404414200010.1046/j.1365-2672.2000.01128.x11021572Search in Google Scholar
Romanio M.R., Coraine L.A., Maielo V.P., Abramczyc M.L., Souza R.L., Oliveira N.F.: Saccharomyces cerevisiae fungemia in a pediatric patient after treatment with probiotics. Rev. Paul. Pediatr. 35, 361–364 (2017)RomanioM.R.CoraineL.A.MaieloV.P.AbramczycM.L.SouzaR.L.OliveiraN.F.Saccharomyces cerevisiae fungemia in a pediatric patient after treatment with probiotics35361364201710.1590/1984-0462/;2017;35;3;00014Search in Google Scholar
Roy U., Jessani L.G., Rudramurthy S.M., Gopalakrishnan R., Dutta S., Chakravarty C., Jillwin J., Chakrabarti A.: Seven cases of Saccharomyces fungaemia related to use of probiotics. Mycoses, 60, 375–380 (2017)RoyU.JessaniL.G.RudramurthyS.M.GopalakrishnanR.DuttaS.ChakravartyC.JillwinJ.ChakrabartiA.Seven cases of Saccharomyces fungaemia related to use of probiotics60375380201710.1111/myc.12604Search in Google Scholar
Saegusa S., Totsuka M., Kaminogawa S., Hosoi T.: Candida albicans and Saccharomyces cerevisiae induce interleukin-8 production from intestinal epithelial-like Caco-2 cells in the presence of butyric acid. FEMS Immunol. Med. Microbiol. 41, 227–235 (2004)SaegusaS.TotsukaM.KaminogawaS.HosoiT.Candida albicans and Saccharomyces cerevisiae induce interleukin-8 production from intestinal epithelial-like Caco-2 cells in the presence of butyric acid41227235200410.1016/j.femsim.2004.03.006Search in Google Scholar
Salonen J.H., Richardson M.D., Gallacher K., Issakainen J., Helenius H., Lehtonen O.P., Nikoskelainen J.: Fungal colonization of haematological patients receiving cytotoxic chemotherapy: emergence of azole-resistant Saccharomyces cerevisiae. J. Hosp. Infect. 45, 293–301 (2000)SalonenJ.H.RichardsonM.D.GallacherK.IssakainenJ.HeleniusH.LehtonenO.P.NikoskelainenJ.Fungal colonization of haematological patients receiving cytotoxic chemotherapy: emergence of azole-resistant Saccharomyces cerevisiae45293301200010.1053/jhin.1999.0718Search in Google Scholar
Sazawal S., Hiremath G., Dhingra U., Malik P., Deb S., Black R.E.: Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect. Dis. 6, 374–382 (2006)SazawalS.HiremathG.DhingraU.MalikP.DebS.BlackR.E.Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials6374382200610.1016/S1473-3099(06)70495-9Search in Google Scholar
Schneider S.M., Le Gall P., Girard-Pipau F., Piche T., Pompei A., Nano J.L., Hébuterne X., Rampal P.: Total artificial nutrition is associated with major changes in the fecal flora. Eur. J. Nutr. 39, 248–255 (2000)SchneiderS.M.Le GallP.Girard-PipauF.PicheT.PompeiA.NanoJ.L.HébuterneX.RampalP.Total artificial nutrition is associated with major changes in the fecal flora39248255200010.1007/s003940070003Search in Google Scholar
Shen N.T., Maw A., Tmanova L.L., Pino A., Ancy K., Crawford C.V., Simon M.S., Evans A.T.: Timely use of probiotics in hospitalized adults prevents Clostridium difficile infection: A systematic review with meta-regression analysis. Gastroenterology, 152, 1889–1900 (2017)ShenN.T.MawA.TmanovaL.L.PinoA.AncyK.CrawfordC.V.SimonM.S.EvansA.T.Timely use of probiotics in hospitalized adults prevents Clostridium difficile infection: A systematic review with meta-regression analysis15218891900201710.1053/j.gastro.2017.02.003Search in Google Scholar
Smith D., Metzgar D., Wills C., Fierer J.: Fatal Saccharomyces cerevisiae aortic graft infection. J. Clin. Microbiol. 40, 2691–2692 (2002)SmithD.MetzgarD.WillsC.FiererJ.Fatal Saccharomyces cerevisiae aortic graft infection4026912692200210.1128/JCM.40.7.2691-2692.2002Search in Google Scholar
Sulik-Tyszka B., Wróblewska M. i wsp.: Experience with Saccharomyces boulardii probiotic in oncohaematological patients. Probiotics Antimicrob. Proteins, 10, 350–355 (2018)Sulik-TyszkaB.WróblewskaM.i wsp.Experience with Saccharomyces boulardii probiotic in oncohaematological patients10350355201810.1007/s12602-017-9332-4Search in Google Scholar
Surawicz C.M., Elmer G.W. i wsp.: The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin. Infect. Dis. 31, 1012–1017 (2000)SurawiczC.M.ElmerG.W.i wsp.The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii3110121017200010.1086/318130Search in Google Scholar
Szajewska H., Kołodziej M., Zalewski B.M.: Systematic review with meta-analysis: Saccharomyces boulardii for treating acute gastroenteritis in children – a 2020 update. Aliment. Pharmacol. Ther. 51, 678–88 (2020)SzajewskaH.KołodziejM.ZalewskiB.M.Systematic review with meta-analysis: Saccharomyces boulardii for treating acute gastroenteritis in children – a 2020 update5167888202010.1111/apt.1565932056266Search in Google Scholar
Tanaka H., Kamogawa T., Aoyagi H., Kato I., Nakajima R.: Invertase production by Saccharomyces cerevisiae protoplasts immobilized in strontium alginate gel beads. J. Biosci. Bioeng. 89, 498–500 (2000)TanakaH.KamogawaT.AoyagiH.KatoI.NakajimaR.Invertase production by Saccharomyces cerevisiae protoplasts immobilized in strontium alginate gel beads89498500200010.1016/S1389-1723(00)89105-7Search in Google Scholar
Thygesen J.B., Glerup H., Tarp B.: Saccharomyces boulardii fungemia caused by treatment with a probioticum. BMJ Case Rep. bcr0620114412 (2012)ThygesenJ.B.GlerupH.TarpB.Saccharomyces boulardii fungemia caused by treatment with a probioticumbcr0620114412201210.1136/bcr.06.2011.4412331679922605806Search in Google Scholar
Tiago F.C.P., Martins F.S., Souza E.L.S., Pimenta P.F.P., Araujo H.R.C., Castro I.M., Brandão R.L., Nicoli J.R.: Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics. J. Med. Microbiol. 61, 1194–1207 (2012)TiagoF.C.P.MartinsF.S.SouzaE.L.S.PimentaP.F.P.AraujoH.R.C.CastroI.M.BrandãoR.L.NicoliJ.R.Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics6111941207201210.1099/jmm.0.042283-022580913Search in Google Scholar
Topaloğlu U., Yilmazcan A., Güloğlu R., Taşçioğlu J., Müftüoğlu T., Unalmişer S.: Hypertonic saline prevents early bacterial translocation in hemorrhagic shock. Surg. Today, 29, 47–50 (1999)TopaloğluU.YilmazcanA.GüloğluR.TaşçioğluJ.MüftüoğluT.UnalmişerS.Hypertonic saline prevents early bacterial translocation in hemorrhagic shock294750199910.1007/BF024829699934831Search in Google Scholar
van der Aa Kühle A., Jespersen L.: The taxonomic position of Saccharomyces boulardii as evaluated by sequence analysis of the D1/D2 domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 region and the mitochondrial cytochrome-c oxidase II gene. Syst. Appl. Microbiol. 26, 564–571 (2003)van der Aa KühleA.JespersenL.The taxonomic position of Saccharomyces boulardii as evaluated by sequence analysis of the D1/D2 domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 region and the mitochondrial cytochrome-c oxidase II gene26564571200310.1078/07232020377086587314666985Search in Google Scholar
Vaughan-Martini A., Martini A.: Facts, myths and legends on the prime industrial microorganism. J. Ind. Microbiol. 14, 514–522 (1995)Vaughan-MartiniA.MartiniA.Facts, myths and legends on the prime industrial microorganism14514522199510.1007/BF015739677662293Search in Google Scholar
Viggiano M., Badetti C., Bernini V., Garabedian M., Manelli J.C.: [Saccharomyces boulardii fungemia in a patient with severe burns]. Ann. Fr. Anesth. Reanim. 14, 356–358 (1995)ViggianoM.BadettiC.BerniniV.GarabedianM.ManelliJ.C.[Saccharomyces boulardii fungemia in a patient with severe burns]14356358199510.1016/S0750-7658(05)80603-3Search in Google Scholar
Williams J.G., Kubelik A.R., Livak K.J., Rafalski J.A., Tingey S.V.: DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res. 18, 6531–6535 (1990)WilliamsJ.G.KubelikA.R.LivakK.J.RafalskiJ.A.TingeyS.V.DNA polymorphisms amplified by arbitrary primers are useful as genetic markers1865316535199010.1093/nar/18.22.65313326061979162Search in Google Scholar
Zunic P., Lacotte J., Pegoix M., Buteux G., Leroy G., Mosquet B., Moulin M.: [Saccharomyces boulardii fungemia. Apropos of a case]. Therapie, 46, 498–499 (1991)ZunicP.LacotteJ.PegoixM.ButeuxG.LeroyG.MosquetB.MoulinM.[Saccharomyces boulardii fungemia. Apropos of a case]464984991991Search in Google Scholar